Clinical trial
A Global Phase 3, Randomized, Placebo Controlled, Double-Blind Trial of AMG 706 in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer (Asian Phase 3 Study)
NCT02629848 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Global Phase 3, Randomized, Placebo Controlled, Double-Blind Trial of AMG 706 in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer (Asian Phase 3 Study)
- Lead sponsor
- Takeda
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- July 31, 2012
- Completion date
- March 31, 2015
- Enrollment
- 401 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.